News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC seeks input on planned study of possible Long COVID treatment
A public comment period will allow patients, caregivers, and researchers to comment on a study to test whether stellate ganglion nerve block (SGB) can help improve Long COVID symptoms.
Announcement
151 Results
151 Results
NIH invites public participation to inform future Long COVID clinical trials
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
Feature
R3 Seminar Recap: Advancing Long COVID Research by Fostering Collaboration between RECOVER and the All of Us Research Program
During the October 8th RECOVER Research Review (R3) Seminar, researchers described how RECOVER and the All of Us Research Program collaborate to advance our understanding of Long COVID. These different National Institutes of Health (NIH) initiatives are sharing health data and developing innovative tools to gain important insights from that data.
R3 Seminar Recap
RECOVER-ENERGIZE enrolls first clinical trial participant
A research team at RECOVER’s South Dakota study site prioritizes diversity and accessibility in clinical trial enrollment.
Feature
Long COVID clinic provides access to research studies and care for University of New Mexico patients
RECOVER researchers at the University of New Mexico study site have built connections between RECOVER studies and the university’s Long COVID clinic to ensure patients have access to resources and care.
Feature
Use of metformin in adults with diabetes linked to lower risk of Long COVID
Findings from this RECOVER study could inform future efforts to prevent Long COVID using repurposed prescription drugs.
News Release
R3 Seminar Recap: Characterization of Long COVID Among Children and Adolescents, Cohort Insights
During the September 10th RECOVER Research Review (R3) Seminar, RECOVER researchers presented some early findings from the RECOVER Pediatric Observational Cohort study. They presented a symptom-based approach for identifying children and adolescents with Long COVID from a study published in JAMA.
R3 Seminar Recap
RECOVER makes study data and biosamples available for ancillary studies
Researchers within and beyond RECOVER can apply to use the initiative’s study data and biosamples for independent research projects.
Announcement
RECOVER researchers create new tool to identify Long COVID in children
Researchers studied symptoms in more than 5,300 children and adolescents in RECOVER’s pediatric observational study, 3,860 of whom had a previous COVID infection.
Feature